Selected article for: "China curve flattening and curve flattening"
Author: Iheagwam, Franklyn Nonso; Rotimi, Solomon Oladapo
Title: Computer-Aided Analysis of Multiple SARS-CoV-2 Therapeutic Targets: Identification of Potent Molecules from African Medicinal Plants
  • Cord-id: 5wefp31y
  • Document date: 2020_9_12
    • ID: 5wefp31y
    Snippet: The COVID-19 pandemic, which started in Wuhan, China, has spread rapidly over the world with no known antiviral therapy or vaccine. Interestingly, traditional Chinese medicine helped in flattening the pandemic curve in China. In this study, molecules from African medicinal plants were analysed as potential candidates against multiple SARS-CoV-2 therapeutic targets. Sixty-five molecules from the ZINC database subset (AfroDb Natural Products) were virtually screened with some reported repurposed t
    Document: The COVID-19 pandemic, which started in Wuhan, China, has spread rapidly over the world with no known antiviral therapy or vaccine. Interestingly, traditional Chinese medicine helped in flattening the pandemic curve in China. In this study, molecules from African medicinal plants were analysed as potential candidates against multiple SARS-CoV-2 therapeutic targets. Sixty-five molecules from the ZINC database subset (AfroDb Natural Products) were virtually screened with some reported repurposed therapeutics against six SARS-CoV-2 and two human targets. Molecular docking, druglikeness, absorption, distribution, metabolism, excretion, and toxicity (ADMET) of the best hits were further simulated. Of the 65 compounds, only three, namely, 3-galloylcatechin, proanthocyanidin B1, and luteolin 7-galactoside found in almond (Terminalia catappa), grape (Vitis vinifera), and common verbena (Verbena officinalis), were able to bind to all eight targets better than the reported repurposed drugs. The findings suggest these molecules may play a role as therapeutic leads in tackling this pandemic due to their multitarget activity.

    Search related documents:
    Co phrase search for related documents
    • absorption property and admet property: 1
    • accessibility score and active site: 1
    • accessibility score and acute respiratory syndrome: 1
    • active metabolite and acute pneumonia: 1
    • active metabolite and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • active site and acute pneumonia: 1, 2, 3
    • active site and acute pneumonia ards respiratory distress syndrome: 1
    • active site and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site and low inhibition: 1, 2, 3, 4, 5, 6, 7
    • active site and low inhibition constant: 1
    • active transport and acute respiratory syndrome: 1
    • activity increase and acute pneumonia: 1
    • activity increase and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • activity increase and low inhibition: 1
    • activity value and acute pneumonia: 1
    • activity value and acute respiratory syndrome: 1, 2, 3, 4, 5, 6
    • acute respiratory syndrome and long qt syndrome: 1, 2
    • acute respiratory syndrome and low inhibition: 1, 2, 3, 4
    • acute respiratory syndrome and low inhibition constant: 1